Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke

András Folyovich, Eniko Biró, Csaba Orbán, Anna Bajnok, B. Vásárhelyi, Gergely Toldi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Stroke-induced immunosuppression (SIIS) leads to severe complications in stroke patients, including an increased risk of infections. However, functional alterations of T lymphocytes during SIIS are poorly described in acute ischemic stroke (AIS). We aimed to characterize Ca2+ influx kinetics in major lymphocyte subsets (CD4, Th1, Th2, CD8) in AIS patients without infection 6 hours and one week after the CNS insult. We also assessed the sensitivity of the above subsets to specific inhibition of the Kv1.3 and IKCa1 lymphocyte K+ channels. We took peripheral blood samples from 12 non-stroke individuals and 12 AIS patients. We used an innovative flow cytometry approach to determine Ca2+ influx kinetics and the surface expression of Kv1.3 channels. Our results indicate that Ca2+ influx kinetics is altered in the Th2 and CD8 subsets in AIS which may play a role in the development of SIIS. Specific inhibition of Kv1.3 channels selectively decreased Ca2+ influx in the CD8 and Th2 subsets of AIS patients. The surface expression of Kv1.3 channels is also altered compared to non-stroke individuals. Kv1.3 channel inhibition might have beneficial therapeutic consequences in AIS, selectively targeting two distinct T cell subsets at two different time points following the CNS insult. Within hours after the insult, it might prevent excessive tissue injury through the inhibition of CD8 cells, while at one week after the insult, it may improve the inflammatory response through the inhibition of Th2 cells, thus reducing the unwanted clinical consequences of SIIS.

Original languageEnglish
Pages (from-to)801-806
Number of pages6
JournalCNS and Neurological Disorders - Drug Targets
Volume13
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Kv1.3 Potassium Channel
Stroke
Lymphocytes
Immunosuppression
Therapeutics
Th2 Cells
Lymphocyte Subsets
T-Lymphocyte Subsets
Infection

Keywords

  • Acute ischemic stroke
  • Calcium influx
  • IKCa1
  • Kv1.3
  • Stroke induced immunosuppression

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology
  • Medicine(all)

Cite this

Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke. / Folyovich, András; Biró, Eniko; Orbán, Csaba; Bajnok, Anna; Vásárhelyi, B.; Toldi, Gergely.

In: CNS and Neurological Disorders - Drug Targets, Vol. 13, No. 5, 2014, p. 801-806.

Research output: Contribution to journalArticle

Folyovich, András ; Biró, Eniko ; Orbán, Csaba ; Bajnok, Anna ; Vásárhelyi, B. ; Toldi, Gergely. / Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke. In: CNS and Neurological Disorders - Drug Targets. 2014 ; Vol. 13, No. 5. pp. 801-806.
@article{379d1b0b30f140fdb6b35b6461867e82,
title = "Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke",
abstract = "Stroke-induced immunosuppression (SIIS) leads to severe complications in stroke patients, including an increased risk of infections. However, functional alterations of T lymphocytes during SIIS are poorly described in acute ischemic stroke (AIS). We aimed to characterize Ca2+ influx kinetics in major lymphocyte subsets (CD4, Th1, Th2, CD8) in AIS patients without infection 6 hours and one week after the CNS insult. We also assessed the sensitivity of the above subsets to specific inhibition of the Kv1.3 and IKCa1 lymphocyte K+ channels. We took peripheral blood samples from 12 non-stroke individuals and 12 AIS patients. We used an innovative flow cytometry approach to determine Ca2+ influx kinetics and the surface expression of Kv1.3 channels. Our results indicate that Ca2+ influx kinetics is altered in the Th2 and CD8 subsets in AIS which may play a role in the development of SIIS. Specific inhibition of Kv1.3 channels selectively decreased Ca2+ influx in the CD8 and Th2 subsets of AIS patients. The surface expression of Kv1.3 channels is also altered compared to non-stroke individuals. Kv1.3 channel inhibition might have beneficial therapeutic consequences in AIS, selectively targeting two distinct T cell subsets at two different time points following the CNS insult. Within hours after the insult, it might prevent excessive tissue injury through the inhibition of CD8 cells, while at one week after the insult, it may improve the inflammatory response through the inhibition of Th2 cells, thus reducing the unwanted clinical consequences of SIIS.",
keywords = "Acute ischemic stroke, Calcium influx, IKCa1, Kv1.3, Stroke induced immunosuppression",
author = "Andr{\'a}s Folyovich and Eniko Bir{\'o} and Csaba Orb{\'a}n and Anna Bajnok and B. V{\'a}s{\'a}rhelyi and Gergely Toldi",
year = "2014",
doi = "10.2174/1871527313666140711090509",
language = "English",
volume = "13",
pages = "801--806",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke

AU - Folyovich, András

AU - Biró, Eniko

AU - Orbán, Csaba

AU - Bajnok, Anna

AU - Vásárhelyi, B.

AU - Toldi, Gergely

PY - 2014

Y1 - 2014

N2 - Stroke-induced immunosuppression (SIIS) leads to severe complications in stroke patients, including an increased risk of infections. However, functional alterations of T lymphocytes during SIIS are poorly described in acute ischemic stroke (AIS). We aimed to characterize Ca2+ influx kinetics in major lymphocyte subsets (CD4, Th1, Th2, CD8) in AIS patients without infection 6 hours and one week after the CNS insult. We also assessed the sensitivity of the above subsets to specific inhibition of the Kv1.3 and IKCa1 lymphocyte K+ channels. We took peripheral blood samples from 12 non-stroke individuals and 12 AIS patients. We used an innovative flow cytometry approach to determine Ca2+ influx kinetics and the surface expression of Kv1.3 channels. Our results indicate that Ca2+ influx kinetics is altered in the Th2 and CD8 subsets in AIS which may play a role in the development of SIIS. Specific inhibition of Kv1.3 channels selectively decreased Ca2+ influx in the CD8 and Th2 subsets of AIS patients. The surface expression of Kv1.3 channels is also altered compared to non-stroke individuals. Kv1.3 channel inhibition might have beneficial therapeutic consequences in AIS, selectively targeting two distinct T cell subsets at two different time points following the CNS insult. Within hours after the insult, it might prevent excessive tissue injury through the inhibition of CD8 cells, while at one week after the insult, it may improve the inflammatory response through the inhibition of Th2 cells, thus reducing the unwanted clinical consequences of SIIS.

AB - Stroke-induced immunosuppression (SIIS) leads to severe complications in stroke patients, including an increased risk of infections. However, functional alterations of T lymphocytes during SIIS are poorly described in acute ischemic stroke (AIS). We aimed to characterize Ca2+ influx kinetics in major lymphocyte subsets (CD4, Th1, Th2, CD8) in AIS patients without infection 6 hours and one week after the CNS insult. We also assessed the sensitivity of the above subsets to specific inhibition of the Kv1.3 and IKCa1 lymphocyte K+ channels. We took peripheral blood samples from 12 non-stroke individuals and 12 AIS patients. We used an innovative flow cytometry approach to determine Ca2+ influx kinetics and the surface expression of Kv1.3 channels. Our results indicate that Ca2+ influx kinetics is altered in the Th2 and CD8 subsets in AIS which may play a role in the development of SIIS. Specific inhibition of Kv1.3 channels selectively decreased Ca2+ influx in the CD8 and Th2 subsets of AIS patients. The surface expression of Kv1.3 channels is also altered compared to non-stroke individuals. Kv1.3 channel inhibition might have beneficial therapeutic consequences in AIS, selectively targeting two distinct T cell subsets at two different time points following the CNS insult. Within hours after the insult, it might prevent excessive tissue injury through the inhibition of CD8 cells, while at one week after the insult, it may improve the inflammatory response through the inhibition of Th2 cells, thus reducing the unwanted clinical consequences of SIIS.

KW - Acute ischemic stroke

KW - Calcium influx

KW - IKCa1

KW - Kv1.3

KW - Stroke induced immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=84905579827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905579827&partnerID=8YFLogxK

U2 - 10.2174/1871527313666140711090509

DO - 10.2174/1871527313666140711090509

M3 - Article

VL - 13

SP - 801

EP - 806

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 5

ER -